Evaluation of the Quality of Life and Economic Burden with Granulocyte-Colony Stimulating Factor in Chinese Breast Cancer Patients Receiving Docetaxel, Epirubicin and Cyclophosphamide

Breast Cancer Patients ◽

Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen

Annals of Oncology ◽

10.1093/annonc/mdl135 ◽

2006 ◽

Vol 17 (8) ◽

pp. 1205-1212 ◽

Cited By ~ 139

Author(s):

M. Martín ◽

A. Lluch ◽

M.A. Seguí ◽

A. Ruiz ◽

M. Ramos ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Health Related Quality ◽

Breast Cancer Patients ◽

Related Quality ◽

Health Related ◽

Cost-effectiveness of prophylactic granulocyte colony-stimulating factor for febrile neutropenia in breast cancer patients receiving FEC-D

Breast Cancer Research and Treatment ◽

10.1007/s10549-015-3309-3 ◽

2015 ◽

Vol 150 (1) ◽

pp. 169-180 ◽

Cited By ~ 7

Author(s):

Esther K. Lee ◽

William W. L. Wong ◽

Maureen E. Trudeau ◽

Kelvin K. W. Chan

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Febrile Neutropenia ◽

Cancer Patients ◽

Breast Cancer Patients ◽

The impact of new European Organisation for Research and Treatment of Cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patients

European Journal of Cancer ◽

10.1016/j.ejca.2007.11.024 ◽

2008 ◽

Vol 44 (3) ◽

pp. 353-365 ◽

Cited By ~ 15

Author(s):

Christoph C. Zielinski ◽

Ahmad Awada ◽

David A. Cameron ◽

Tanja Cufer ◽

Miguel Martin ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Breast Cancer Patients ◽

European Organisation ◽

Cancer Guidelines ◽

The Impact ◽

Mitoxantrone plus vinorelbine with granulocyte-colony stimulating factor (G-CSF) support in advanced breast cancer patients. A dose and schedule finding study

Breast Cancer Research and Treatment ◽

10.1007/bf00668204 ◽

1995 ◽

Vol 35 (2) ◽

pp. 147-156 ◽

Cited By ~ 7

Author(s):

G. Frasci ◽

G. Comella ◽

P. Comella ◽

F. Salzano ◽

L. Cremone ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Finding Study ◽

Stimulating Factor ◽

Factor G

Quality of Life in Phase II Trials: a Study of Methodology and Predictive Value in Patients With Advanced Breast Cancer Treated With Paclitaxel Plus Granulocyte Colony-Stimulating Factor

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/87.17.1316 ◽

1995 ◽

Vol 87 (17) ◽

pp. 1316-1322 ◽

Cited By ~ 75

Author(s):

A. D. Seidman ◽

R. Portenoy ◽

T. -J. Yao ◽

J. Lepore ◽

E. K. Mont ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Predictive Value ◽

Phase Ii Trials ◽

Prophylactic administration of granulocyte colony-stimulating factor in epirubicin and cyclophosphamide chemotherapy for Japanese breast cancer patients: a retrospective study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-019-03948-6 ◽

2019 ◽

Vol 84 (5) ◽

pp. 1107-1114

Author(s):

Takumi Sakurada ◽

Sanako Bando ◽

Yoshito Zamami ◽

Kenshi Takechi ◽

Masayuki Chuma ◽

...

Keyword(s):

Breast Cancer ◽

Retrospective Study ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Prophylactic Administration ◽

Cell cycle status and apoptosis of hematopoietic progenitor cells released into the peripheral blood after taxanes and granulocyte colony-stimulating factor in breast cancer patients.

Oncology Reports ◽

10.3892/or.7.3.585 ◽

2000 ◽

Author(s):

M Danova ◽

C Porta ◽

S Ferrari ◽

S Brugnatelli ◽

G Comolli ◽

...

Keyword(s):

Breast Cancer ◽

Cell Cycle ◽

Cancer Patients ◽

Hematopoietic Progenitor Cells ◽

Breast Cancer Patients ◽

Hematopoietic Progenitor ◽

Cell Cycle Status ◽

Adjuvant Docetaxel and Cyclophosphamide (DC) with Prophylactic Granulocyte Colony-Stimulating Factor (G-CSF) on Days 8 &12 in Breast Cancer Patients: A Retrospective Analysis

PLoS ONE ◽

10.1371/journal.pone.0107273 ◽

2014 ◽

Vol 9 (10) ◽

pp. e107273 ◽

Cited By ~ 7

Author(s):

Rinat Yerushalmi ◽

Hadar Goldvaser ◽

Aaron Sulkes ◽

Irit Ben-Aharon ◽

Daniel Hendler ◽

...

Keyword(s):

Breast Cancer ◽

Retrospective Analysis ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Stimulating Factor ◽

Factor G

Neutrophil Recovery in Breast Cancer Patients Receiving Docetaxel-Containing Chemotherapy with and without Granulocyte Colony-Stimulating Factor Prophylaxis

Oncology ◽

10.1159/000479067 ◽

2017 ◽

Vol 93 (5) ◽

pp. 323-328

Author(s):

Maureen J. Aarts ◽

Birgit E. Vriens ◽

Maaike de Boer ◽

Frank P. Peters ◽

Caroline M. Mandigers ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Neutrophil Recovery ◽

Effect of Primary Prophylactic Granulocyte-Colony Stimulating Factor Use on Incidence of Neutropenia Hospitalizations for Elderly Early-stage Breast Cancer Patients Receiving Chemotherapy

Medical Care ◽

10.1097/mlr.0b013e318215c42e ◽

2011 ◽

Vol 49 (7) ◽

pp. 649-657 ◽

Cited By ~ 10

Author(s):

Suja S. Rajan ◽

Gary H. Lyman ◽

Sally C. Stearns ◽

William R. Carpenter

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Breast Cancer Patients ◽